Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors

BACKGROUND: Decreased tumor content (TC) in resection specimens after neoadjuvant therapy is used to predict prognosis. We investigated whether TC assessed in biopsy specimens or the shift in TC from baseline to on-treatment can be used accordingly to predict response in patients with rare tumors wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapia, Coya, Aung, Phyu P., Roy-Chowdhuri, Sinchita, Xu, Mingxuan, Ouyang, Fengying, Alshawa, Anas, Hajjar, Joud, Singh, Gopal, Yang, Vincent, Castillo, Lilibeth, Le, Hung, Murthy, Ravi, Stephen, Bettzy, Hess, Kenneth R, Wistuba, Ignacio, Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204618/
https://www.ncbi.nlm.nih.gov/pubmed/32303619
http://dx.doi.org/10.1136/jitc-2020-000665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204618/
https://www.ncbi.nlm.nih.gov/pubmed/32303619
http://dx.doi.org/10.1136/jitc-2020-000665

Ejemplares similares